PF-06256142
PF-06256142 is a potent, selective, CNS-penetrant and orally active agonist of the D1 receptor, with an EC50 and Ki of 33 nM and 12 nM, respectively. PF-06256142 has the potential for the research of schizophrenia and Parkinson's disease[1].
Product Specifications
CAS Number
[1609583-14-3]
UNSPSC
12352005
Target
Dopamine Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
COVID-19-immunoregulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/PF-06256142.html
Purity
99.90
Solubility
DMSO : 200 mg/mL (ultrasonic)
Smiles
CC1=[C@]([C@]2=C(C)N=CC3=NC=CN32)C=CC(OC4=C(C=CO5)C5=CC=N4)=C1
Molecular Formula
C21H16N4O2
Molecular Weight
356.38
References & Citations
[1]Davoren JE, et al. Discovery and Lead Optimization of Atropisomer D1 Agonists with Reduced Desensitization. J Med Chem. 2018 Nov 15.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
D1 Receptor
Available Sizes
Explore Other Products
Browse additional items from our catalog
C10orf2, CT (PEO1, C10orf2, Twinkle protein, mitochondrial, Progressive external ophthalmoplegia 1 protein, T7 gp4-like protein with intramitochondrial nucleoid localization, T7-like mitochondrial DNA helicase) (MaxLight 650) discontinued
Tspan 13 (TSPAN13) (NM_014399) Human Tagged ORF Clone Lentiviral Particle
Sav1 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat)